Skip to main content
. 2022 Sep 1;140(9):1009–1019. doi: 10.1182/blood.2021015114

Figure 1.

Figure 1.

OS in patients aged <65 years with stage II to IV PTCL. (A-B) OS according to 2 calendar periods (1989-2008 and 2009-2018) (A) and according to histologic subtypes ALK ALCL, ALK+ ALCL, ALCL NOS, AITL, and PTCL NOS (B).